Company: ISRG
Filing Date: 2025-10-22
Form Type: 10-Q
Source: 0001035267-25-000209
Chunk: 25

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-10-22
Form: 10-Q
Item: Item 1
Chunk 25
---
 employee stock plans4.6 — 367.5 — — 367.5 — 367.5 Shares withheld related to net share settlement of equity awards(0.7)— (7.4)(250.1)— (257.5)— (257.5)Share-based compensation expense related to employee stock plans— — 503.7 — — 503.7 — 503.7 Net income attributable to Intuitive Surgical, Inc.— — — 1,636.9 — 1,636.9 — 1,636.9 Other comprehensive income (loss)— — — — 25.1 25.1 (0.1)25.0 Cash dividends declared and paid by joint venture— — — — — — (8.0)(8.0)Net income attributable to noncontrolling interest in joint venture— — — — — — 12.6 12.6 Ending balance356.2 $0.4 $9,440.2 $6,129.8 $12.9 $15,583.3 $94.2 $15,677.5 

Stock Repurchase ProgramThe Company’s Board of Directors (the “Board”) has authorized an aggregate of $13.0 billion of funding for the Company’s common stock repurchase program (the “Repurchase Program”) since its establishment in March 2009. The most recent authorization occurred in May 2025, when the Board increased the authorized amount available under the Repurchase Program to $4.0 billion, including amounts remaining under previous authorization. As of September 30, 2025, the remaining amount of share repurchases authorized by the Board under the Repurchase Program was approximately $1.9 billion.

The following table summarizes stock repurchase activities (in millions, except per share amounts): Three Months Ended September 30,Nine Months Ended September 30, 2025202420252024Shares repurchased4.0 — 4.4 — Average price per share$479.60 $— $482.66 $— Value of shares repurchased$1,919.6 $— $2,100.6 $— 

18

Accumulated Other Comprehensive Income (Loss), Net of